Account | Description | FY2014 Spending |
FY2015 GAA |
---|---|---|---|
4512-0106 | HIV/AIDS Drug Program Manufacturer Rebates Retained Revenue For the department of public health, which may expend for the human immunodeficiency virus and acquired immune deficiency syndrome drug assistance program an amount not to exceed $7,500,000 from revenues received from pharmaceutical manufacturers participating in the section 340B rebate program of the Public Health Service Act, administered by the federal Health Resources and Services Administration and the Office of Pharmacy Affairs; provided, that these services shall include activities that would be eligible for coverage through the Ryan White Care Act |
7,500,000 | 7,500,000 |